COPD, inflammation and its modulation by phosphodiesterase 4 inhibitors: time to look beyond the FEV1
- PMID: 16424403
- DOI: 10.1378/chest.129.1.5
COPD, inflammation and its modulation by phosphodiesterase 4 inhibitors: time to look beyond the FEV1
Comment on
-
Cilomilast for COPD: results of a 6-month, placebo-controlled study of a potent, selective inhibitor of phosphodiesterase 4.Chest. 2006 Jan;129(1):56-66. doi: 10.1378/chest.129.1.56. Chest. 2006. PMID: 16424413 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical